Diclo axapharm 2%
Diclo axapharm 2% is a medicine authorised by Swissmedic under authorisation number 69727. The authorisation holder is axapharm ag. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 08 February 2024 and the authorisation is valid without a time limit. ATC code M02AA15 places the medicine in the group Topical products for joint and muscular pain.
| Authorisation number | 69727 |
|---|---|
| Name | Diclo axapharm 2% |
| Full name | Diclo axapharm 2%, Gel |
| Authorisation holder | axapharm ag |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | M02AA15 |
| First authorisation | 08 February 2024 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Diclo axapharm 2%, Gel | D | 08 February 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 4 | 50 | g | M02AA15 | 07.10.4. | D |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Diclo axapharm 2% authorised in Switzerland?
Yes. Diclo axapharm 2% is authorised by Swissmedic under authorisation number 69727, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Diclo axapharm 2% have?
Diclo axapharm 2% is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of Diclo axapharm 2%?
The authorisation holder is axapharm ag. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.